22.626 articles found

Involuntary emotional expression disorder in Alzheimer's disease - psychopharmacotherapy aspects.

Mimica N, Drmić S, Presecki P.

Psychiatr Danub · 2009-09-01

PMID: 19794369

My hands shake--classification and treatment of tremor.

Sirisena D, Williams DR.

Aust Fam Physician · 2009-09-01

PMID: 19893794

Treatments for progressing Parkinson's disease: a clinical case scenario study.

Maertens de Noordhout A, Santens P, Gérard JM, Gonce M, Jeanjean A, Flamez A, Pickut B, Van Zandijcke M, Pahwa R, Study Group Parkinson's Disease: From Guidelines to Practice in Belgium.

Acta Neurol Belg · 2009-09-01

PMID: 19902812

Treatment with 1,2,3,4,-tetrahydroisoquinoline affects glutamate release in the striatum but not the binding of [3H]MK-801 to NMDA receptors in the dopaminergic structures of the rat brain.

Lorenc-Koci E, Gołembiowska K, Pietraszek M, Wardas J.

Pharmacol Rep · 2009-09-01

DOI: 10.1016/s1734-1140(09)70135-5PMID: 19904002

[Optimisation of treatment of Parkinson's disease with levodopa].

Białecka M, Adamiak U, Gawrońska-Szklarz B.

Neurol Neurochir Pol · 2009-09-01

PMID: 20054747

[History of surgical treatment of appendicitis].

Meljnikov I, Radojcić B, Grebeldinger S, Radojcić N.

Med Pregl · 2009-09-01

PMID: 20391748

Perspectives on recent advances in the understanding and treatment of Parkinson's disease.

Schapira AH, Agid Y, Barone P, Jenner P, Lemke MR, Poewe W, Rascol O, Reichmann H, Tolosa E.

Eur J Neurol · 2009-08-30

DOI: 10.1111/j.1468-1331.2009.02793.xPMID: 19723294

TREATMENT OF NEURODEGENERATIVE DISEASE THROUGH INTRACRANIAL DELIVERY OF SIRNA

KAEMMERER WILLIAM F.

· 2009-08-27

Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances.

Pérez V, Marin C, Rubio A, Aguilar E, Barbanoj M, Kulisevsky J.

J Neural Transm (Vienna) · 2009-08-27

DOI: 10.1007/s00702-009-0291-0PMID: 19710996

ORALLY BIOAVAILABLE PRODRUGS OF (+)-3-HYDROXYMORPHINAN FOR PARKINSON'S DISEASE PREVENTION OR TREATMENT.

LEE JINHWA, JUNG MYUNG EUN, KIM JONG YUP, SONG KWANG-SEOP, LEE SUK HO, SON EUN JUNG, HAN HO KYUN, LEE MINWOO, KIM JEONGMIN, JIM MIN JU.

· 2009-08-26

Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease.

Charles J, Templier I, Leroux D, Salameire D, Robert C, Lantuejoul S, Leccia MT.

Pigment Cell Melanoma Res · 2009-08-26

DOI: 10.1111/j.1755-148x.2009.00624.xPMID: 19708914

Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection.

Leaver KR, Allbutt HN, Creber NJ, Kassiou M, Henderson JM.

Brain Res Bull · 2009-08-25

DOI: 10.1016/j.brainresbull.2009.08.013PMID: 19712727